Life Technologies Acquires BAC | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies today announced that it has acquired Dutch firm BAC BV for an undisclosed sum.

BAC makes protein purification products and will expand Life Tech's portfolio in bioprocessing by adding the firm's affinity ligands to Life Tech's Poros brand of chromatography resins for purification of therapeutic products. The new technologies also complement Life Tech's Gibco brand of cell culture media products and the Applied Biosystems SEQ rapid molecular kits for containment and impurity testing of biotherapeutic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.